Top

Published in:

01-12-2018 | Neurology and Preclinical Neurological Studies - Original Article

Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder

Authors: Xudong Li, Shuhong Jia, Zhi Zhou, Yi Jin, Xiangfei Zhang, Chunlei Hou, Wenjing Zheng, Pei Rong, Jinsong Jiao

Published in: Journal of Neural Transmission | Issue 12/2018

Abstract

Idiopathic rapid eye movement sleep behavior disorder (iRBD) likely represents the prodromal stage of synucleinopathy. The present study investigated how levels of serum uric acid (UA) affect cognition and motor function in patients with iRBD. A total of 42 patients with iRBD and 45 healthy controls were included. All participants were given cognitive tests and motor assessments. Serum UA concentrations were measured. The patients were further divided into two groups (high or low UA) according to serum UA level. The level of serum UA was similar between the patients with iRBD and the healthy controls, whereas the patients showed impaired executive, memory, and visuospatial functions. The patients with low UA levels had longer durations of RBD. Lower scores involving attention, executive function, and language domain were also found in the patients with low UA, whereas the scores of the patients with high UA were similar to those of the healthy controls. Regarding memory domain, the low UA group had worse scores than the healthy controls, whereas the scores of high UA group fell between those of the low UA group and the healthy controls. Motor function was not affected in any of the groups. UA affects cognitive function but not motor function in patients with iRBD, which could contribute to its antioxidant and neuroprotective roles.

American Academy of Sleep Medicine (2015) The international classification of sleep disorders, 2nd edn. American Academy of Sleep Medicine, Westchester, pp 148–152

Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson’s disease. Mov Disord 30:1600–1611CrossRef

Boeve BF (2010) REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 1184:15–54CrossRef

Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788CrossRef

Cheung RW, Cheung MC, Chan AS (2004) Confrontation naming in Chinese patients with left, right or bilateral brain damage. J Int Neuropsychol Soc 10:46–53CrossRef

Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494–499CrossRef

Dai XY, Ryan JJ, Paolo AM, Harrington RG (1990) Factor analysis of the mainland Chinese version of the Wechsler Adult Intelligence Scale (WAIS-RC) in a brain-damaged sample. Int J Neurosci 55:107–111CrossRef

Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC (2016) Biomarkers for dementia and mild cognitive impairment in Parkinson’s disease. Mov Disord 31:861–881CrossRef

Desrosiers J, Hebert R, Bravo G, Dutil E (1995) The Purdue Pegboard Test: normative data for people aged 60 and over. Disabil Rehabil 17:217–224CrossRef

Ellmore TM, Castriotta RJ, Hendley ML, Aalbers BM, Furr-Stimming E, Hood AJ, Suescun J, Beurlot MR, Hendley RT, Schiess MC (2013) Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder. Sleep 36:1885–1892CrossRef

Fantini ML, Farini E, Ortelli P, Zucconi M, Manconi M, Cappa S, Ferini-Strambi L (2011) Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder. Sleep 34:619–625PubMedPubMedCentral

Ferini-Strambi L, DiGioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF (2004) Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist? Neurology 62:41–45CrossRef

Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS (2010) Amyloid imaging of Lewy body-associated disorders. Mov Disord 25:2516–2523CrossRef

Gagnon JF, Vendette M, Postuma RB, Desjardins C, Massicotte-Marquez J, Panisset M, Montplaisir J (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47CrossRef

Gonzalez-Aramburu I, Sanchez-Juan P, Sierra M, Fernández-Juan E, Sánchez-Quintana C, Berciano J, Combarros O, Infante J (2014) Serum uric acid and risk of dementia in Parkinson’s disease. Parkinsonism Relat Disord 20:637–639CrossRef

Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pavía J, Santamaria J, Tolosa E (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 10:797–805CrossRef

Iranzo A, Santamaria J, Tolosa E (2016) Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol 15:405–419CrossRef

Khan AA, Quinn TJ, Hewitt J, Fan Y, Dawson J (2016) Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age 38:16CrossRef

Li X, Zhou Z, Jia S, Hou C, Zheng W, Rong P, Jiao J (2016) Cognitive study on Chinese patients with idiopathic REM sleep behavior disorder. J Neurol Sci 366:82–86CrossRef

Lu L, Bigler ED (2000) Performance on original and a Chinese version of trail making test part B: a normative bilingual sample. Appl Neuropsychol 7:243–246CrossRef

Maetzler W, Stapf AK, Schulte C, Hauser AK, Lerche S, Wurster I, Schleicher E, Melms A, Berg D (2011) Serum and cerebrospinal fluid uric acid levels in Lewy body disorders: associations with disease occurrence and amyloid-β pathway. J Alzheimers Dis 27:119–126CrossRef

Massicotte-Marquez J, Decary A, Gagnon JF, Vendette M, Mathieu A, Postuma RB, Carrier J, Montplaisir J (2008) Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 70:1250–1257CrossRef

Moccia M, Picillo M, Erro R, Vitale C, Longo K, Amboni M, Santangelo G, Palladino R, Capo G, Orefice G, Barone P, Pellecchia MT (2015a) Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson’s disease. Eur J Neurol 22:93–98CrossRef

Moccia M, Pappatà S, Erro R, Picillo M, Vitale C, Amboni M, Longo K, Palladino R, Barone P, Pellecchia MT (2015b) Uric acid relates to dopamine transporter availability in Parkinson’s disease. Acta Neurol Scand 131:127–131CrossRef

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRef

Osterrieth PA (1944) Le test de copie d’une figure complexe. Arch Psychol 30:206–356

Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148CrossRef

Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66:845–851CrossRef

Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel W, Dauvilliers Y, Ju YE, Puligheddu M, Sonka K, Pelletier A, Santamaria J, Frauscher B, Leu-Semenescu S, Zucconi M, Terzaghi M, Miyamoto M, Unger MM, Carlander B, Fantini ML, Montplaisir JY (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77:830–839CrossRef

Rahayel S, Montplaisir J, Monchi O, Bedetti C, Postuma RB, Brambati S, Carrier J, Joubert S, Latreille V, Jubault T, Gagnon JF (2015) Patterns of cortical thinning in idiopathic rapid eye movement sleep behavior disorder. Mov Disord 30:680–687CrossRef

Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K (1992) Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Brain Cogn 18:70–87CrossRef

Scherfler C, Frauscher B, Schocke M, Iranzo A, Gschliesser V, Seppi K, Santamaria J, Tolosa E, Högl B, Poewe W (2011) White and gray matter abnormalities in idiopathic REM sleep behaviour disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol 69:400–407CrossRef

Schlesinger I, Schlesinger N (2008) Uric acid in Parkinson’s disease. Mov Disord 23:1653–1657CrossRef

Shao X, Lu W, Gao F, Li D, Hu J, Li Y, Zuo Z, Jie H, Zhao Y, Cen X (2016) Uric acid induces cognitive dysfunction through hippocampal inflammation in rodents and humans. J Neurosci 36:10990–11005CrossRef

Shen L, Ji HF (2013) Low uric acid levels in patients with Parkinson’s disease: evidence from meta-analysis. BMJ Open 3:e003620CrossRef

Sprenger FS, Stefanova N, Gelpi E (2015) Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology 85:1761–1768CrossRef

Strauss E, Sherman EM, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary, 3rd edn. Oxford University Press, New York

Terzaghi M, Sinforiani E, Zucchella C, Zambrelli E, Pasotti C, Rustioni V, Manni R (2008) Cognitive performance in REM sleep behaviour disorder: a possible early marker for neurodegenerative disease? Sleep Med 9:343–351CrossRef

Uribe-San Martín R, Venegas Francke P, López Illanes F, Jones Gazmuri A, Salazar Rivera J, Godoy Ferńndez J, Santín Martínez J, Juri C (2013) Plasma urate in REM sleep behavior disorder. Mov Disord 28:1150–1151CrossRef

Vieru E, Köksal A, Mutluay B, Dirican AC, Altunkaynak Y, Baybas S (2016) The relation of serum uric acid levels with l-Dopa treatment and progression in patients with Parkinson’s disease. Neurol Sci 37:743–747CrossRef

Vilas D, Iranzo A, Tolosa E, Aldecoa I, Berenguer J, Vilaseca I, Martí C, Serradell M, Lomeña F, Alós L, Gaig C, Santamaria J, Gelpi E (2016) Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol 15:708–718CrossRef

Wang Y, Wang ZW, Yang YC, Wu HJ, Zhao HY, Zhao ZX (2015) Validation of the rapid eye movement sleep behavior disorder screening questionnaire in China. J Clin Neurosci 22:1420–1424CrossRef

Wu P, Yu H, Peng S, Dauvilliers Y, Wang J, Ge J, Zhang H, Eidelberg D, Ma Y, Zuo C (2014) Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain 137:3122–3128CrossRef

Zhang MY, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, Qu GY, Grant I, Yu E, Levy P et al (1990) The prevalence of dementia and Alzheimer’s disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 27:428–437CrossRef

Title: Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder
Authors: Xudong Li
Shuhong Jia
Zhi Zhou
Yi Jin
Xiangfei Zhang
Chunlei Hou
Wenjing Zheng
Pei Rong
Jinsong Jiao
Publication date: 01-12-2018
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 12/2018
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-018-1935-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2018

The frequency and diagnostic accuracy of hand deformities in Parkinson’s disease

Projection length stimulated by oxytocin is modulated by the inhibition of calcium signaling in U-87MG cells

Desacylghrelin but not acylghrelin is reduced during smoking cessation

Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis

Chronic oral methylphenidate treatment increases microglial activation in rats

Emotional facedness in Parkinson’s disease